Email:
Amyloids are a hallmark of neurodegenerative diseases and systemic amyloidoses. The examination of patient-derived amyloid structures reveals a correlation between the amyloid assembly and clinicopathology, but the role of amyloids in these illnesses is still largely unknown. The capability to design proteins that exhibit specific amyloids would allow for the identification of pathological biomarkers and the development of effective treatments.
Postdoctoral Scholar